Both in Pharmaceuticals
Wave Life Sciences vs Sagimet Biosciences Inc. Series A
Over the past year WVE returned −56.9% and SGMT returned +23.4%; their daily moves had a correlation of 0.04.
WVE −56.9% SGMT +23.4%Growth of $1, one year, split-adjusted
| Metric | WVE | SGMT |
|---|---|---|
| Price | $3.58 | $9.95 |
| Market cap | $706.1M | $705.5M |
| Today | +1.70% | +2.68% |
| 1 month | −4.5% | +10.2% |
| 6 months | −50.1% | +28.9% |
| Year to date | −78.9% | +68.1% |
| 1 year | −60.4% | +16.8% |
| Revenue growth (YoY) | +72.9% | — |
| Gross margin | 100.0% | — |
| Net margin | −470.5% | — |
| P/E (TTM) | — | — |
| Price / sales | 10.0× | — |
| Net cash | $430.7M | $240.1M |
| Dividend yield | — | — |
| Volatility (60d) | 62.9% | 73.1% |
| Short % of float | 17.0% | 18.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).